To further define the role of key TH17 cytokines in inhibiting chemokine expression, we treated human epithelial colon cancer cells (HCT116) with recombinant IL-17A and IL-22 and then determined the chemokine expression after DSS treatment. The gene discussed is IL22; the disease is malignant colon neoplasm.